Sedana Medical AB (publ) (FRA:7D2A)

Germany flag Germany · Delayed Price · Currency is EUR
0.837
-0.030 (-3.46%)
At close: Dec 4, 2025
-23.91%
Market Cap 90.84M
Revenue (ttm) 17.87M
Net Income (ttm) -3.68M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.837
Previous Close 0.867
Day's Range 0.837 - 0.837
52-Week Range 0.579 - 1.804
Beta n/a
RSI 42.28
Earnings Date Feb 12, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1999
Employees 109
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 7D2A
Full Company Profile

Financial Performance

In 2024, Sedana Medical AB's revenue was 178.75 million, an increase of 16.17% compared to the previous year's 153.87 million. Losses were -10.67 million, -82.09% less than in 2023.

Financial numbers in SEK Financial Statements

News

There is no news available yet.